Human Organoids Market Size, Share, Growth, Forecast 2030

Human Organoids Market

Human Organoids Market - By Usability (Customized and Ready-To-Use), By Product (Pancreas, Lung, Kidney, Liver Models, and GIT), By End-User (Pharma-Biotech, Academia, and CROs), By Application (Toxicity, Pathology, and Personalized & Regenerative Drugs), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Biotechnology Report Format : PDF Pages: 120 Report Code: ZMR-6472 Published Date: Jul-2021 Status : Published
Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 1.3 Billion USD 2.9 Billion 17.3% 2020

Human Organoids Market Size And Industry Analysis

The global Human Organoids market accrued earnings worth approximately 1.3 (USD Billion) in 2020 and is predicted to gain revenue of about 2.9(USD Billion) by 2028, is set to record a CAGR of nearly 17.3% over the period from 2021 to 2028.

The report offers assessment and analysis of the Human Organoids market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Human Organoids Market: Overview

Dependence of biological research activities on animal prototypes have proven to be challenging tasks for addressing questions particular to understanding of human ailment. However, with onset of human organoids it is possible for re-creating physiology & architecture of human organs in comprehensive detail. In addition to this, human organoids offer new avenues for studying human ailment as well as supplement animal models. They have been utilized for studying contagious ailments, genetic diseases, and cancers through use of genetically engineering of stem cells of human beings. Apart from this, human organoids have the ability of reducing requirement for animal tests. Organoids are produced from human cell sources encompassing induced pluripotent stem cells, adult tissue-specific stem tissues, and embryonic stem cells.  

Human Organoids Market: Growth Drivers

With organoids having ability of studying human growth and model disease procedures with scrutiny & comprehensive analysis same as research on non-human models, the market for human organoids is anticipated to spur in the upcoming years. In addition to this, patient-based human organoids are likely to speed up healthcare research activities. Moreover, they are expected to create novel avenues for regenerative medicine & tissue engineering processes, thereby driving market trends. Apparently, human organoids have ability for producing information & tools for preclinical tests such as medicine testing & development. They can help in proficiently studying of complex ailment phenotypes and genetic difference among persons through utilization of patient-derived tissue cells. All these aforementioned aspects will drive growth of human organoids industry over forecast timespan.

Furthermore, breakthroughs in stem cell researches have brought a paradigm shift in field of medicine & biology, thereby paving a way for discovery in human biology & healthcare advancements. Furthermore, human organoids – an in vitro 3D structures- is a key revolution that recapitulate developing & tissue organizing as well as resembling body organs in humans. This, in turn, will create lucrative growth avenues for human organoids industry over assessment timeline. Human organoids possesses potential of overcoming limitations of biomedical studies targeted at getting mechanistic insights into human growth, producing patient-matching cell tissue sources for production of regenerative drugs, and generating human disease models.

Human Organoids Market: Report Scope

Report Attributes Report Details
Report Name Human Organoids Market Research Report
Market Size in 2020 USD 1.3 Billion
Market Forecast in 2028 USD 2.9 Billion
Growth Rate CAGR of 17.3%
Number of Pages 210
Key Companies Covered BioIVT, ZenBio, Thermo Fisher Scientific, Cyprio, Corning, CELLINK, Biopredic International, Hurel Corporation, Emulate, Kerafast, InSphero, MIMETAS, and Kirkstall
Segments Covered By Usability, By Product, By Application, By End-User and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2020
Historical Year 2018 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

This will further expedite market size in the upcoming years. Major applications of human organoids (also referred as 3D organoids) include disease modelling, tissue engineering, organ development, transplantation, senescence, organogenesis, and differentiation pathways. In addition to this, human organoids find lucrative use in bio-banking due to breakthroughs in personalized medicine & cellular reprogramming sectors. They are also used as major tools for modelling cancer, neuropsychiatric ailments, and neurodegenerative disorders, and evolutionary studies. All these above-mentioned aspects will steer business space over the decade to come.

Competitive Insights

Key participants profiled in the study and enlarging business scope include BioIVT, ZenBio, Thermo Fisher Scientific, Cyprio, Corning, CELLINK, Biopredic International, Hurel Corporation, Emulate, Kerafast, InSphero, MIMETAS, and Kirkstall.

Regional Insights

North America To Lead Overall Market Growth Over 2021-2028

The expansion of human organoids industry in North America during forecast period is due to large-scale use of human organoids by CROs, pharma firms, universities, and biotech firms in countries such as the U.S. and Canada. In addition to this, high acceptance of new techniques in medical sector along with large-scale annual spending on healthcare activities by Canadian and the U.S. governments will spearhead growth of human organoids market in sub-continent over the upcoming years.

Global Human Organoids Market SizeRequest Free Sample

Favorable government guidelines pertaining to use of human organoids in pharma, healthcare, drug development, and medical research or biotech sectors will create lucrative growth avenues for human organoids market in North America over the assessment period.

Human Organoids Market: Competitive Space

The global Human Organoids market profiles key players such as:

  • BioIVT
  • ZenBio
  • Thermo Fisher Scientific
  • Cyprio
  • Corning
  • CELLINK
  • Biopredic International
  • Hurel Corporation
  • Emulate
  • Kerafast
  • InSphero
  • MIMETAS
  • Kirkstall

The global Human Organoids Market is segmented as follows:

By End-User

  • Pharma-Biotech
  • Academia
  • CROs

By Usability

  • Customized
  • Ready-To-Use

By Product

  • Pancreas
  • Lung
  • Kidney
  • Liver Models
  • GIT

By Application

  • Toxicity
  • Pathology
  • Personalized & Regenerative Drugs

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

With organoids having ability of studying human growth and model disease procedures with scrutiny & comprehensive analysis same as research on non-human models, the market for human organoids is set to spur in the upcoming years. In addition to this, patient-based human organoids are likely to speed up healthcare research activities. Moreover, they are expected to create novel avenues for regenerative medicine & tissue engineering processes, thereby driving market trends. Apparently, human organoids have ability for producing information & tools for preclinical tests such as medicine testing & development. They can help in proficiently studying of complex ailment phenotypes and genetic difference among persons through utilization of patient-derived tissue cells. All these aforementioned aspects will drive growth of human organoids industry over forecast timespan.

Furthermore, breakthroughs in stem cell researches have brought a paradigm shift in field of medicine & biology, thereby paving a way for discovery in human biology & healthcare advancements. Furthermore, human organoids – an in vitro 3D structures- is a key revolution that recapitulate developing & tissue organizing as well as resembling body organs in humans. This, in turn, will create lucrative growth avenues for human organoids industry over assessment timeline. 

 

According to Zion market research report, the global Human Organoids market accrued earnings worth approximately 1.3 (USD Billion) in 2020 and is predicted to gain revenue of about 2.9(USD Billion) by 2028, is set to record a CAGR of nearly 17.3% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to large-scale use of human organoids by CROs, pharma firms, universities, and biotech firms in countries such as the U.S. and Canada. In addition to this, high acceptance of new techniques in medical sector along with large-scale annual spending on healthcare activities by Canadian and the U.S. governments will spearhead growth of human organoids market in sub-continent over the upcoming years. Favorable government guidelines pertaining to use of human organoids in pharma, healthcare, drug development, and medical research or biotech sectors will create lucrative growth avenues for human organoids market in North America over the assessment period.

The key market participants include BioIVT, ZenBio, Thermo Fisher Scientific, Cyprio, Corning, CELLINK, Biopredic International, Hurel Corporation, Emulate, Kerafast, InSphero, MIMETAS, and Kirkstall.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed